136 related articles for article (PubMed ID: 28417251)
41. Introduction to Irreversible Electroporation--Principles and Techniques.
Thomson KR; Kavnoudias H; Neal RE
Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
[TBL] [Abstract][Full Text] [Related]
42. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile.
Chen X; Ren Z; Yin S; Xu Y; Guo D; Xie H; Zhou L; Wu L; Jiang J; Li H; Sun J; Zheng S
Cytokine; 2017 May; 93():44-50. PubMed ID: 28506570
[TBL] [Abstract][Full Text] [Related]
43. Irreversible electroporation: an in vivo study with dorsal skin fold chamber.
Qin Z; Jiang J; Long G; Lindgren B; Bischof JC
Ann Biomed Eng; 2013 Mar; 41(3):619-29. PubMed ID: 23180025
[TBL] [Abstract][Full Text] [Related]
44. The Feasibility of Enhancing Susceptibility of Glioblastoma Cells to IRE Using a Calcium Adjuvant.
Wasson EM; Ivey JW; Verbridge SS; Davalos RV
Ann Biomed Eng; 2017 Nov; 45(11):2535-2547. PubMed ID: 28849278
[TBL] [Abstract][Full Text] [Related]
45. Characterization of Conductivity Changes During High-Frequency Irreversible Electroporation for Treatment Planning.
Zhao Y; Bhonsle S; Dong S; Lv Y; Liu H; Safaai-Jazi A; Davalos RV; Yao C
IEEE Trans Biomed Eng; 2018 Aug; 65(8):1810-1819. PubMed ID: 29989932
[TBL] [Abstract][Full Text] [Related]
46. Irreversible electroporation: a new ablation modality--clinical implications.
Rubinsky B; Onik G; Mikus P
Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
[TBL] [Abstract][Full Text] [Related]
47. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode.
Neal RE; Singh R; Hatcher HC; Kock ND; Torti SV; Davalos RV
Breast Cancer Res Treat; 2010 Aug; 123(1):295-301. PubMed ID: 20191380
[TBL] [Abstract][Full Text] [Related]
48. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
49. Microsecond and nanosecond electric pulses in cancer treatments.
Breton M; Mir LM
Bioelectromagnetics; 2012 Feb; 33(2):106-23. PubMed ID: 21812011
[TBL] [Abstract][Full Text] [Related]
50. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
51. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings.
Niessen C; Jung EM; Beyer L; Pregler B; Dollinger M; Haimerl M; Scheer F; Stroszczynski C; Wiggermann P
Clin Hemorheol Microcirc; 2015; 61(2):135-41. PubMed ID: 26410867
[TBL] [Abstract][Full Text] [Related]
52. In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment.
Neal RE; Rossmeisl JH; D'Alfonso V; Robertson JL; Garcia PA; Elankumaran S; Davalos RV
Ann Biomed Eng; 2014 Mar; 42(3):475-87. PubMed ID: 24165928
[TBL] [Abstract][Full Text] [Related]
53. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes].
Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402
[TBL] [Abstract][Full Text] [Related]
54. Irreversible Electroporation for Colorectal Liver Metastases.
Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
[TBL] [Abstract][Full Text] [Related]
55. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
56. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
57. Cardiac impact of R-wave triggered irreversible electroporation therapy.
Kostrzewa M; Tueluemen E; Rudic B; Rathmann N; Akin I; Henzler T; Liebe V; Schoenberg SO; Borggrefe M; Diehl SJ
Heart Rhythm; 2018 Dec; 15(12):1872-1879. PubMed ID: 30017817
[TBL] [Abstract][Full Text] [Related]
58. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model.
Qian T; Chen M; Gao F; Meng F; Gao X; Yin H
Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024
[TBL] [Abstract][Full Text] [Related]
59.
Sun JH; Zhu TY; Chen XH; Nie CH; Ren ZG; Zhou GH; Zhou TY; Yin SY; Peng ZY; Wu LM; Zhang XX; Wang WL; Zheng SS
Int J Clin Exp Pathol; 2018; 11(3):1273-1280. PubMed ID: 31938222
[TBL] [Abstract][Full Text] [Related]
60. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
Hosein PJ; Echenique A; Loaiza-Bonilla A; Froud T; Barbery K; Rocha Lima CM; Yrizarry JM; Narayanan G
J Vasc Interv Radiol; 2014 Aug; 25(8):1233-1239.e2. PubMed ID: 24861662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
